# A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects

> **NCT00907985** · PHASE1 · TERMINATED · sponsor: **GlaxoSmithKline** · enrollment: 12 (actual)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Placebo
- **DRUG:** Vofopitant
- **DRUG:** Lamotrigine

## Key facts

- **NCT ID:** NCT00907985
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-05-15
- **Primary completion:** 2010-06-10
- **Final completion:** 2010-06-10
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Slow recruitment; trial unlikely to reach completion
- **Last updated:** 2017-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00907985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00907985, "A Study to Evaluate the Effect of Single Doses of Drug A (Lamotrigine) and Drug B (Vofopitant) Alone and in Combination on Resting Motor Threshold in Healthy Subjects". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT00907985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*